Aclaris Therapeutics, Inc. (ACRS) Earnings History
Annual and quarterly earnings data from 2013 to 2025
Loading earnings history...
ACRS EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
ACRS Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 73.3% | -975.9% | -829.6% |
| 2024 | 85.1% | -758.2% | -705.5% |
| 2023 | 42.1% | -311.6% | -283.1% |
| 2022 | 59.8% | -302.0% | -292.1% |
| 2021 | 30.3% | -1327.1% | -1344.0% |
Download Data
Export ACRS earnings history in CSV or JSON format
Free sign-in required to download data
Aclaris Therapeutics, Inc. (ACRS) Earnings Overview
As of May 8, 2026, Aclaris Therapeutics, Inc. (ACRS) reported trailing twelve-month net income of -$65M, reflecting +69.0% year-over-year growth. The company earned $-0.53 per diluted share over the past four quarters, with a net profit margin of -829.6%.
Looking at the long-term picture, ACRS's historical earnings data spans multiple years. The company achieved its highest annual net income of -$5M in fiscal 2013.
Aclaris Therapeutics, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including NKTR (-$164M net income, -297.1% margin), PTGX (-$115M net income, -282.8% margin), DAWN (-$107M net income, -67.8% margin), ACRS has room to improve margins relative to the peer group. Compare ACRS vs NKTR →
ACRS Earnings vs Peers
Earnings metrics vs comparable public companies
ACRS Historical Earnings Data (2013–2025)
13 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$65M | +50.8% | -$76M | $-0.53 | -829.6% | -975.9% |
| 2024 | -$132M | -49.3% | -$142M | $-1.71 | -705.5% | -758.2% |
| 2023 | -$88M | -1.8% | -$97M | $-1.27 | -283.1% | -311.6% |
| 2022 | -$87M | +4.4% | -$90M | $-1.33 | -292.1% | -302.0% |
| 2021 | -$91M | -78.1% | -$90M | $-1.60 | -1344.0% | -1327.1% |
| 2020 | -$51M | +68.4% | -$51M | $-1.20 | -787.0% | -785.4% |
| 2019 | -$161M | -21.6% | -$111M | $-3.46 | -3817.2% | -2627.3% |
| 2018 | -$133M | -93.7% | -$135M | $-4.03 | -1315.4% | -1341.9% |
| 2017 | -$69M | -42.5% | -$72M | $-2.44 | -4071.5% | -4303.2% |
| 2016 | -$48M | -133.8% | -$49M | $-2.25 | - | - |
See ACRS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ACRS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ACRS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonACRS — Frequently Asked Questions
Quick answers to the most common questions about buying ACRS stock.
Is ACRS growing earnings?
ACRS EPS is $-0.53, with earnings growth accelerating to +69.0%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-65M.
What are ACRS's profit margins?
Aclaris Therapeutics, Inc. net margin is -829.6%, with operating margin at -975.9%. Below-average margins reflect competitive or cost pressures.
How consistent are ACRS's earnings?
ACRS earnings data spans 2013-2025. The accelerating earnings trend is +69.0% YoY. Historical data enables comparison across business cycles.